Skip to main content

Table 2 Risk factors related to clinical characteristics a

From: Risk factors for multi-drug resistant Acinetobacter baumanniibacteremia in patients with colonization in the intensive care unit

Parameters

Non-Bacteremic

(n = 92)

Bacteremic

(n = 108)

Odds

Ratio

95% CI

P-value

Immunosuppressive status b

45 (48.9)

89 (82.4)

4.89

2.57 - 9.29

< 0.001

Neutropenia c

2 (2.2)

25 (23.1)

13.55

3.11 - 59.0

0.001

Prior history of

     

   ICU admission

2 (2.2)

6 (5.6)

2.65

0.52 - 13.45

0.240

   Hospitalization

24 (26.1)

41 (38.0)

1.73

0.95 - 3.18

0.075

APACHE II score at the time of

     

   ICU admission (point)

21.6 ± 8.2

24.0 ± 7.9

1.04

1.00 - 1.08

0.035

   Colonization (point)

17.0 (12.0 - 20.0)

22.0 (17.0 - 28.0)

1.12

1.07 - 1.17

<0.001

Duration (days)

     

   Of hospitalization

31.0 (20.0 - 65.3)

32.0 (20.0 - 5.0)

0.99

0.99 - 1.00

0.333

   Of ICU hospitalization

19.2 ± 21.3

22.8 ± 20.4

1.01

0.99 - 1.02

0.234

   From ICU admission to colonization

7.1 ± 7.7

7.2 ± 5.9

1.00

0.96 - 1.01

0.923

   Of exposure to riskd

6.0 (3.0 - 13.8)

3.0 (1.0 - 6.0)

0.96

0.94 - 0.99

<0.001

Mechanical ventilator care

87 (94.6)

105 (97.2)

2.01

0.47 - 8.66

0.348

   Maintenance of MVe

15 (17.2)

91 (86.7)

31.2

14.14 - 68.83

< 0.001

   Duration of MV (day)

9.0 (5.0 - 16.0)

21.5 (12.3 - 47.0)

1.04

1.01 - 1.08

0.001

Shock at the time of

     

   ICU admission

66 (71.7)

80 (74.1)

1.13

0.60 - 2.10

0.711

   Colonization

28 (30.4)

65 (60.2)

3.46

1.92 - 6.22

< 0.001

Acute renal failure at the time of

     

   ICU admission

22 (23.9)

31 (28.7)

1.28

0.68 - 2.42

0.445

   Colonization

20 (21.7)

41 (38.0)

2.20

1.17 - 4.14

0.014

  1. a Data are presented as numbers (percentages for categorical variables or interquartile range for continuous variables) unless otherwise indicated. Plus-minus values are means ± standard deviation
  2. b Immunosupression was defined as a history of any of the following: corticosteroid therapy for 15 days (at least 10 mg/day of prednisone or an equivalent drug), seropositivity for human immunodeficiency virus, solid organ transplantation, bone marrow transplantation, radiation therapy or chemotherapy for an underlying malignancy during the 6 months prior to hospital admission, and acquired immune deficiency disorder (hypogammaglobulinemia, combined variable immunodeficiency).
  3. c Neutropenia is defined as absolute neutrophil count measured in cells per microliter of blood less than 1,500
  4. d Time from colonization to the date of discharge from the intensive care unit for non-bacteremic patients or to the date a positive-culture was obtained for bacteremic patients
  5. e Number of patients/total number of patients with mechanical ventilation (percentages)
  6. ICU intensive care unit
  7. APACHE Acute Physiological Assessment and Chronic Health Evaluation
  8. MV mechanical ventilation
  9. CI confidential interval